pyruvic acid has been researched along with thromboxane b2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, XL; Long, YD; Luo, W; Xiao, LM; Yao, LY; Zhang, YL | 1 |
Katayama, Y; Memezawa, H; Minamisawa, H; Shimizu, J; Sugimoto, S; Suzuki, S; Terashi, A | 1 |
Ando, H; Kobayashi, K; Nakatani, T; Sakamoto, Y | 1 |
3 other study(ies) available for pyruvic acid and thromboxane b2
Article | Year |
---|---|
[Protective action of sophoridine on acute myocardial infarction in anesthetized dogs].
Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Creatine Kinase; Dogs; Female; Lactates; Lactic Acid; Male; Matrines; Myocardial Infarction; Myocardium; Pyruvates; Pyruvic Acid; Quinolizines; Thromboxane B2 | 1991 |
[Protective effect of thromboxane A2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia].
Topics: Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Cerebral Arteries; Lactates; Lactic Acid; Male; Microscopy, Electron, Scanning; Pyrimidines; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred SHR; Thromboxane B2; Thromboxane-A Synthase; Trapidil | 1986 |
Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine Nucleotides; Ammonia; Analysis of Variance; Animals; Blood Gas Analysis; Blood Glucose; Energy Metabolism; Hydrogen-Ion Concentration; Lactic Acid; Liver; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Pyruvic Acid; Rabbits; Reperfusion Injury; Thromboxane B2 | 1996 |